Intravenous 5-fluoro-2′-deoxycytidine administered with tetrahydrouridine increases the proportion of p16-expressing circulating tumor cells in patients with advanced solid tumors
Geraldine O.’Sullivan Coyne, Lihua Wang, Jennifer Zlott, Lamin Juwara, Joseph M. Covey, Jan H. Beumer, Mihaela C. Cristea, Edward M. Newman, Stephen Koehler, Jorge J. Nieva, Agustin A. Garcia, David R. Gandara, Brandon Miller, Sonny Khin, Sarah B. Miller, Seth M. Steinberg, Larry Rubinstein, Ralph E. Parchment, Robert J. Kinders, Richard L. PiekarzShivaani Kummar, Alice P. Chen, James H. Doroshow
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Intravenous 5-fluoro-2′-deoxycytidine administered with tetrahydrouridine increases the proportion of p16-expressing circulating tumor cells in patients with advanced solid tumors'. Together they form a unique fingerprint.